Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy

Published:2019-09-19 Issue:4 Volume:70 Page:1437-1442
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Brown Zachary J.¹²^ORCID,Greten Tim F.¹³,Heinrich Bernd¹

Affiliation:

1. Thoracic and GI Malignancies Branch, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda MD

2. Department of Surgery Rutgers Robert Wood Johnson Medical School New Brunswick NJ

3. National Cancer Institute, Center for Cancer Research Liver Cancer Program National Institutes of Health Bethesda MD

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30633

Reference61 articles.

1. Hepatocellular carcinoma

2. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

3. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

4. Immune surveillance by the liver

5. The yin and yang of evasion and immune activation in HCC

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the cytotoxicity of a new gold(I) complex towards hepatocellular carcinoma by inhibiting TrxR activity;Acta Biochimica et Biophysica Sinica;2024-09-01

2. CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinoma;Scientific Reports;2024-08-28

3. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

4. Construction of CDKN2A-related competitive endogenous RNA network and identification of GAS5 as a prognostic indicator for hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-04-15

5. C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients;World Journal of Gastrointestinal Oncology;2024-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3